Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark I. Hamilton
Mark I. Hamilton
University College London
Medicine
Inflammatory bowel disease
Gastroenterology
Pathology
Infliximab
4
Papers
82
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Small bowel obstruction caused by a migrated Obalon gastric bariatric balloon: nonsurgical management by antegrade double-balloon panenteroscopy
2017
Endoscopy
Erasmia Vlachou
Shamindra Direkz
Alberto Murino
Peter Wylie
Mark I. Hamilton
Charles Murray
Edward J. Despott
Show All
Source
Cite
Save
Citations (5)
The role of dietary supplements in inflammatory bowel disease: A systematic review
2016
European Journal of Gastroenterology & Hepatology
Roberta Elisa Rossi
Tara Whyand
Charles Murray
Mark I. Hamilton
Dario Conte
Martyn Caplin
Show All
Source
Cite
Save
Citations (29)
Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab.
2016
European Journal of Gastroenterology & Hepatology
I Parisi
J O'Beirne
Roberta Elisa Rossi
Emmanuel Tsochatzis
Pinelopi Manousou
E. Theocharidou
Mark I. Hamilton
Charles Murray
O. Epstein
A.K. Burroughs
Show All
Source
Cite
Save
Citations (10)
Anti-tumour necrosis factor agent and liver injury: Literature review, recommendations for management
2014
World Journal of Gastroenterology
Roberta Elisa Rossi
Ioanna Parisi
Edward J. Despott
Andrew K. Burroughs
J O'Beirne
Dario Conte
Mark I. Hamilton
Charles Murray
Show All
Source
Cite
Save
Citations (38)
1